- Home
- ESE vs LNTH Comparison
ESE vs LNTH Comparison
Compare ESE & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESE | LNTH |
|---|---|---|
| Founded | 1990 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.9B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ESE | LNTH |
|---|---|---|
| Price | $275.71 | $73.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $250.00 | $78.00 |
| AVG Volume (30 Days) | 206.9K | ★ 672.3K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.12% | N/A |
| EPS Growth | ★ 193.15 | N/A |
| EPS | 1.11 | ★ 2.60 |
| Revenue | $37,000,000.00 | ★ $343,374,000.00 |
| Revenue This Year | $20.87 | N/A |
| Revenue Next Year | $6.87 | $0.46 |
| P/E Ratio | $248.65 | ★ $28.26 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $134.78 | $47.27 |
| 52 Week High | $291.31 | $111.29 |
Technical Indicators
Market Signals| Indicator | ESE | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 72.02 | 73.51 |
| Support Level | $198.85 | $73.11 |
| Resistance Level | $291.31 | $73.72 |
| Average True Range (ATR) | 10.00 | 2.26 |
| MACD | 0.93 | 0.72 |
| Stochastic Oscillator | 74.68 | 89.21 |
Price Performance
Historical ComparisonAbout ESE ESCO Technologies Inc.
ESCO Technologies Inc sells engineered products and systems for utility, industrial, aerospace, and commercial applications. The firm operates in three segments: Aerospace & Defense (A&D), Utility Solutions Group (USG), and RF Test & Measurement (Test). The Aerospace and Defense segment designs and manufactures specialty filtration and naval products. The USG segment provides diagnostic testing solutions. The Test segment provides its customers with the ability to identify, measure, and contain magnetic, electromagnetic, and acoustic energy.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.